08/22/2024 6:23 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 6:23 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:11 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:13 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 7:00 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024 6:47 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024 7:03 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/14/2024 3:38 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024 3:05 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 3:05 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/31/2024 3:05 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 4:55 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024 4:56 PM | Mancini Marianna (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024 4:58 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024 4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 3:10 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 6:10 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 6:46 PM | Viking Therapeutics (Filer)
| Form S-8 POS | |
05/22/2024 6:54 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 3:33 PM | Viking Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024 7:51 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 3:04 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 8:27 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2024 3:02 PM | Mancini Marianna (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2024 7:42 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 3:05 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 3:15 PM | Viking Therapeutics (Filer)
| Form ARS | |
03/27/2024 7:50 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:51 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 7:52 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 6:08 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 6:50 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:52 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:54 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:52 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 3:05 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 4:21 PM | Viking Therapeutics (Filer)
| Form 424B5 | |
02/27/2024 6:04 AM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 7:59 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:38 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:40 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
02/07/2024 4:24 PM | Viking Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/07/2024 4:33 PM | Viking Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/31/2024 7:39 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:32 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 8:05 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 3:23 PM | Lian Brian (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024 12:24 PM | STATE STREET CORP (Filed by) Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/19/2024 7:35 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:36 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 3:26 PM | MILLENNIUM MANAGEMENT LLC (Filed by) Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/04/2024 8:35 PM | Viking Therapeutics (Issuer) ZANTE GREG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:36 PM | Mancini Marianna (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:37 PM | Lian Brian (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:22 PM | FOEHR MATTHEW W (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:24 PM | MACARTNEY LAWSON (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:25 PM | Rouan Sarah Kathryn (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:27 PM | Rowland Charles A Jr (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 8:28 PM | SINGLETON J MATTHEW (Reporting) Viking Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 7:12 PM | Viking Therapeutics (Subject) ZANTE GREG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 3:30 PM | VIKING GLOBAL INVESTORS LP (Filed by) Viking Therapeutics (Subject)
| Form SC 13G | |
10/25/2023 4:05 PM | Viking Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/25/2023 3:24 PM | Viking Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |